Clinical expertise

Dr Paramit Chowdhury specialises in renal (kidney) transplantation including anti-rejection therapy.

He regularly treats patients with conditions such as:

  • general nephrology (kidney care)
  • chronic kidney disease
  • hypertension
  • atypical haemolytic uraemic syndrome
  • pregnancy and renal disease

He performs treatments such as:

  • kidney biopsy
  • dialysis supervision
  • percutaneous native and transplant renal biopsy
  • haemodialysis
  • pre-pregnancy counselling


Biography

Dr Paramit Chowdhury is a substantive consultant nephrologist at Guy’s and St Thomas’ hospitals.

He qualified in medicine from King’s College London in 1992 and went on to completed his general medical training in London and Leeds. He was then appointed to the South Thames Renal training schemed with posts at Guy’s, King’s College, St George’s and Kent and Canterbury Hospitals.

He completed a PhD in innate immunity and renal disease at King’s College, London and was awarded a certificate of specialist training in renal medicine and in 2007 he completed his training and became a consultant at Guy’s Hospital.


Research

Dr Paramit Chowdhury has special interest in renal transplantation including biomarkers, atypical haemolytic uraemic syndrome (HUS), pregnancy and renal disease, transition care. His clinical workload covers all aspects of renal medicine, including general nephrology and haemodialysis.

He has a specific interest in renal transplantation including anti-rejection therapy. He also has special experience in pre-pregnancy counselling and management of renal and transplant patients during pregnancy. He has extensive experience in percutaneous biopsy of both native and transplant kidneys.

He is active in clinical research, being the chief investigator of a multi-centre study trying to identify biomarkers of rejection following renal transplantation. He is also site principal investigator for two large UK wide studies looking at anti-rejection treatment following renal transplantation (3C Study) and intravenous iron in haemodialysis patients (PIVOTAL).